Abstract:OBJECTIVES: Cell-free DNA based non-invasive prenatal testing (NIPT) has been shown with closeto-diagnosis sensitivity and specificity in detecting fetal T21, T18, and T13. Future development of this technology focuses on detection of other chromosomal aneuploidies, and more importantly chromosome copy number variants (CNVs) and single-gene mutations. Validation studies were carried out to demonstrate the feasibility of detecting CNVs and single-gene disease by exploiting the cell-free DNA testing strategy and existing NIPT platforms. METHOD: For testing CNVs, 35 plasma samples with known fetal CNVs (>10 Mb in size) were recruited, together with 1077 plasma samples with normal fetal karyotypes as the control. The samples were blindly tested using the routine NIPT testing pipelines adopted at the clinical laboratories of BGI, and analyzed with the proprietary FCAPS protocol. Results were compared to the karyotyping results to calculate the sensitivity and specificity of the NIPT test. For testing single-gene disease, we developed a unique haplotype-assisted approach which was validated in a Maple Syrup Urine Disease (MSUD) case. In a trio family (father, mother in early pregnancy, and proband), targeted sequencing (180X) of the known genes causing MSUD was used to identify the disease causative mutations in the proband child and parents. At 13 gestational weeks, maternal plasma DNA and genomic DNA of the trio family were tested with a customized array at the sequencing depth of 40X and 20X respectively to retrieve the SNPs information for the purpose of parental haplotypes deduction. Linkage analysis and Hidden Markov Model were then used to construct the fetal genotype and haplotype flanking the MSUD mutation region. RESULTS: For CNV detection, with on average 4–5 M reads per sample and the existing NIPT platforms, we were able to use the FCAPS analytic protocol to identify 32 positive samples in total of 35, and generated 6 false positive cases, leading to overall sensitivity and specificity of 91.4% and 99.4% respectively. False positive rate and false negative rate of the test were 0.56% and 0.28% respectively. We also showed that with an increased sequencing depth, the detection power of the test can be further improved. In the MUSD case, deep targeted sequencing in the trio family identified that the proband child carries a missense mutation and a large deletion on BCKDHA gene, which were inherited from the mother and father respectively. With the SNP markers of the proband and parents, parental haplotype of chromosome 19 in 6148 loci were recovered. After fetal haplotype construction, the same alleles as that of the proband in the causative gene BCKDHA were inherited to the fetus, indicating that the fetus is a MSUD patient. This result was later confirmed by invasive diagnosis, and led to a well-informed decision after post-test counselling. CONCLUSIONS: We demonstrate the successful application of NIPT in detection of CNVs larger than 10 Mb without changing much to the current pipelines of aneuploidy detection. It has the potential to be integrated into the current NIPT test and offer extra benefits to the clinical service. The haplotype-assisted approach we developed requires minimum genetic information to accurately predict fetal condition. It has the clinical potential for noninvasive prenatal diagnosis of single gene disease for family with a proband child and seeks a second healthy child.

Cloning and Sequence Analysis of SLC25A13 Transcripts in Human Amniocytes.

Molecular Analysis of SLC25A13 Gene in Human Peripheral Blood Lymphocytes: Marked Transcript Diversity, and the Feasibility of Cdna Cloning As a Diagnostic Tool for Citrin Deficiency

Molecular Diagnosis of Citrin Deficiency in an Infant with Intrahepatic Cholestasis: Identification of a 21.7kb Gross Deletion That Completely Silences the Transcriptional and Translational Expression of the Affected SLC25A13 Allele.

SLC25A13 Cdna Cloning Analysis Using Peripheral Blood Lymphocytes Facilitates the Identification of a Large Deletion Mutation: Molecular Diagnosis of an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency.

Identification of a LargeSLC25A13Deletion Via Sophisticated Molecular Analyses Using Peripheral Blood Lymphocytes in an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD): A Clinical and Molecular Study

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

[A Novel SLC25A13 Variant and the Resultant Aberrant Transcript Identified in a Pedigree Affected with Citrin Deficiency].

Analysis of SLC25A13 Gene Mutations and Prenatal Diagnosis for 20 Families Affected with Citrin Deficiency

Detection of SLC25A13 gene mutation in a family with primary carnitine deficiency and prenatal diagnosis

Noninvasive detection of chromosomal CNV and single gene disease by massively parallel sequencing of cfDNA

SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China

Inspissated Bile Syndrome in an Infant with Citrin Deficiency and Congenital Anomalies of the Biliary Tract and Esophagus: Identification and Pathogenicity Analysis of a Novel SLC25A13 Mutation with Incomplete Penetrance.

The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia

Bioinformatic and Functional Analysis of Promoter Region of Human SLC25A13 Gene.

In-house multiplex ligation-dependent probe amplification assay for citrin deficiency: analytical validation and novel exonic deletions in SLC25A13

Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: A clinical, genetic and transcriptional analysis

Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations.

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]